ストックスクリーナーアプリを入手
24.42
0.33%
0.08
プレマーケット:
23.89
-0.53
-2.17%
前日終値:
$24.34
開ける：
$24.18
24時間の取引高:
745.02K
Relative Volume:
0.89
時価総額：
$3.52B
収益：
$340.81M
当期純損益:
$-419.65M
株価収益率:
-22.40
EPS:
-1.09
ネットキャッシュフロー:
$-402.10M
1週間 パフォーマンス:
-17.58%
1か月 パフォーマンス:
-11.49%
6か月 パフォーマンス:
+21.31%
1年 パフォーマンス:
+27.25%
1日の値動き範囲:
$23.82
$24.83
1週間の範囲:
$23.53
$29.80
52週間の値動き範囲:
$14.56
$33.33
Denali Therapeutics Inc Stock (DNLI) Company Profile
名前
Denali Therapeutics Inc
セクター
電話
(650) 866-8548
住所
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
DNLI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| DNLI | 24.42 | 3.52B | 340.81M | -419.65M | -402.10M | -1.09 |
| VRTX | 451.23 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.35 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.82 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.79 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-12-13 | 開始されました | Citigroup | Buy |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-10-24 | 再開されました | Cantor Fitzgerald | Overweight |
| 2023-09-06 | 開始されました | B. Riley Securities | Buy |
| 2023-01-30 | 開始されました | SVB Securities | Outperform |
| 2022-12-05 | 開始されました | Cowen | Outperform |
| 2022-11-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-11-02 | 開始されました | BofA Securities | Buy |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-12-10 | 再開されました | Raymond James | Mkt Perform |
| 2021-09-21 | 開始されました | Oppenheimer | Outperform |
| 2021-09-01 | 開始されました | SMBC Nikko | Outperform |
| 2021-05-18 | 開始されました | UBS | Buy |
| 2021-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-02-10 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-08-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-02-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-02-24 | 開始されました | Jefferies | Buy |
| 2020-02-19 | 開始されました | Stifel | Hold |
| 2020-01-27 | アップグレード | Goldman | Neutral → Buy |
| 2019-09-26 | 開始されました | Wedbush | Neutral |
| 2019-09-13 | 開始されました | Nomura | Buy |
| 2019-08-09 | 開始されました | BTIG Research | Buy |
| 2019-06-26 | 開始されました | H.C. Wainwright | Buy |
| 2018-11-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 開始されました | Janney | Buy |
| 2018-03-12 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-01-02 | 開始されました | Evercore ISI | Outperform |
| 2018-01-02 | 開始されました | Goldman | Neutral |
| 2018-01-02 | 開始されました | JP Morgan | Overweight |
| 2018-01-02 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Denali Therapeutics Inc (DNLI) 最新ニュース
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $38.90 Consensus Target Price from Brokerages - MarketBeat
Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging - MSN
Denali Therapeutics updates bylaws, aligns with SEC rules - Investing.com India
Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.3%Here's What Happened - MarketBeat
Denali Has A Neurodegenerative Edge Despite Market Skepticism (NASDAQ:DNLI) - Seeking Alpha
Los Angeles Capital Management LLC Trims Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely - Yahoo Finance
State of New Jersey Common Pension Fund D Sells 25,613 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Capital Research Global Investors Expands Stake in Denali Therap - GuruFocus.com
FMR LLC Expands Stake in Denali Therapeutics Inc - GuruFocus.com
BofA raises Denali Therapeutics target to $34 on BLA plans By Investing.com - Investing.com Canada
Denali Therapeutics executive sells shares worth $465,286 - Investing.com India
Denali Therapeutics executive sells shares worth $465,286 By Investing.com - Investing.com Canada
Baillie Gifford & Co. Sells 417,709 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Principal Financial Group Inc. Increases Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics stock soars to 52-week high of $32.17 - Investing.com India
Denali Therapeutics stock soars to 52-week high of $32.17 By Investing.com - Investing.com Canada
Learn to Evaluate (DNLI) using the Charts - Stock Traders Daily
Denali Therapeutics (NASDAQ:DNLI) Reaches New 12-Month HighStill a Buy? - MarketBeat
Wedbush Cuts Earnings Estimates for Denali Therapeutics - Defense World
Brokers Issue Forecasts for DNLI Q1 Earnings - MarketBeat
HC Wainwright Has Bearish Forecast for DNLI FY2024 Earnings - MarketBeat
Equities Analysts Offer Predictions for DNLI FY2024 Earnings - MarketBeat
Wellington Management Group LLP's Strategic Acquisition in Denal - GuruFocus.com
HC Wainwright Issues Pessimistic Forecast for DNLI Earnings - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Given "Buy" Rating at HC Wainwright - MarketBeat
Denali Therapeutics earnings missed by $0.03, revenue topped estimates - Investing.com UK
Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire
Denali Therapeutics director Vicki Sato sells $83,375 in stock - Investing.com India
abrdn plc Sells 209,356 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat
Thinking about buying stock in QuickLogic, Ventyx Biosciences, D - GuruFocus.com
Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo Finance
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $38.22 Average Price Target from Analysts - MarketBeat
Zacks Research Issues Pessimistic Forecast for DNLI Earnings - MarketBeat
Denali Therapeutics CEO Ryan Watts sells shares worth $1.1 million - Investing.com
Insider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) CEO Sells 40,000 Shares of Stock - MarketBeat
(DNLI) Investment Analysis and Advice - Stock Traders Daily
The five-year returns have been notable for Denali Therapeutics (NASDAQ:DNLI) shareholders despite underlying losses increasing - Simply Wall St
Denali Therapeutics Inc (DNLI) stock on the rise: An overview - US Post News
Denali Therapeutics Inc (DNLI)’s Market Momentum: Closing Strong at 26.83, Down -4.18 - The Dwinnex
This trade activity should not be overlooked: Denali Therapeutics Inc (DNLI) - SETE News
Denali Therapeutics Inc (DNLI) receives a Mkt perform rating from Raymond James - Knox Daily
Denali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $28.00 at JPMorgan Chase & Co. - Defense World
Hunter Syndrome Therapeutic Market Is in Huge Demand:Takeda, Denali Therapeutics, ArmaGen, Inventiva, Green Cross Corp, – IndiaPolitics.com - IndiaPolitics.com
Denali Therapeutics shares hold steady from BTIG By Investing.com - Investing.com South Africa
Denali Therapeutics (NASDAQ:DNLI) Shares Down 3.8% on Analyst Downgrade - MarketBeat
Denali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Now - Insider Monkey
Denali Therapeutics Inc (DNLI) 財務データ
収益
当期純利益
現金流量
EPS
0.69%
6.90%
大文字化:
|
ボリューム (24 時間):